US Stock MarketDetailed Quotes

XERS Xeris Pharmaceuticals

Watchlist
  • 3.540
  • -0.070-1.94%
Close Jan 6 16:00 ET
  • 3.550
  • +0.010+0.28%
Post 19:24 ET
527.75MMarket Cap-8.23P/E (TTM)

Xeris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
43.16%-8.31M
24.71%-10.35M
22.33%-20.3M
54.30%-47.02M
146.35%7.47M
17.71%-14.61M
33.31%-13.74M
46.00%-26.14M
-7.70%-102.89M
44.31%-16.12M
Net income from continuing operations
-29.12%-15.74M
24.38%-15.01M
-12.75%-18.98M
34.23%-62.26M
-3.56%-13.39M
44.17%-12.19M
24.22%-19.84M
50.07%-16.83M
22.87%-94.66M
74.54%-12.93M
Operating gains losses
----
----
----
1,148.84%3.16M
2,385.71%320K
----
----
----
-142.88%-301K
-101.77%-14K
Depreciation and amortization
-6.94%3.12M
-6.21%3.15M
1.04%3.21M
3.88%13.16M
-6.97%3.26M
9.31%3.36M
9.83%3.36M
4.91%3.18M
574.19%12.67M
289.66%3.5M
Deferred tax
-592.44%-3.32M
210.96%749K
--307K
12.29%-1.25M
---1.25M
--675K
---675K
--0
---1.42M
----
Other non cash items
206.09%383K
192.79%206K
-244.51%-2.79M
-182.46%-3M
68.28%-1.6M
-212.81%-361K
-104.17%-222K
-126.72%-811K
277.94%3.63M
-2,257.26%-5.05M
Change In working capital
106.08%674K
-398.68%-3.39M
59.35%-5.63M
82.09%-6.29M
682.15%17.51M
-343.06%-11.08M
120.90%1.13M
42.77%-13.86M
-396.52%-35.15M
-117.58%-3.01M
-Change in receivables
108.27%1.3M
-891.50%-5.03M
6,043.33%1.78M
37.44%-8.37M
304.38%6.77M
-793.36%-15.74M
126.76%635K
99.49%-30K
-114.43%-13.37M
-837.64%-3.31M
-Change in inventory
51.32%-1.05M
69.53%-2.27M
38.90%-2.33M
-98.31%-14.8M
74.55%-1.4M
-30.09%-2.15M
-4,922.30%-7.43M
-2,331.21%-3.82M
-0.63%-7.47M
-142.08%-5.51M
-Change in prepaid assets
-37.32%215K
-86.31%281K
-51.67%-1.86M
182.48%3.21M
280.34%2.04M
118.67%343K
337.78%2.05M
-2,012.07%-1.23M
-218.15%-3.89M
-130.71%-1.13M
-Change in payables and accrued expense
-153.46%-2.15M
-76.80%688K
25.32%-5.18M
146.21%6.44M
701.88%6.39M
90.79%4.02M
186.42%2.97M
39.85%-6.94M
-162.46%-13.93M
-106.78%-1.06M
-Change in other current liabilities
-47.66%358K
-90.76%302K
118.93%762K
113.24%818K
199.33%893K
--684K
--3.27M
23.75%-4.03M
---6.18M
---899K
-Change in other working capital
12.84%2M
848.01%2.63M
-45.18%1.2M
-33.70%6.42M
-68.29%2.82M
173.26%1.77M
-125.34%-352K
273.71%2.18M
12,671.43%9.68M
2,265.21%8.9M
Cash from discontinued investing activities
Operating cash flow
43.16%-8.31M
24.71%-10.35M
22.33%-20.3M
54.30%-47.02M
146.35%7.47M
17.71%-14.61M
33.31%-13.74M
46.00%-26.14M
-7.70%-102.89M
44.31%-16.12M
Investing cash flow
Cash flow from continuing investing activities
-32.35%9.91M
-45.54%4.6M
55.32%-19.65M
-117.42%-6M
62.17%14.87M
118.44%14.66M
-28.78%8.45M
-754.84%-43.98M
-64.82%34.46M
-74.95%9.17M
Capital expenditure reported
74.78%-87K
74.35%-397K
31.09%-164K
-331.87%-2.26M
0.00%-132K
-96.02%-345K
-567.24%-1.55M
-1,587.50%-238K
51.71%-524K
-0.76%-132K
Net business purchase and sale
----
----
----
--0
----
----
----
----
--0
----
Net investment purchase and sale
-33.33%10M
-50.00%5M
55.45%-19.49M
-110.69%-3.74M
61.29%15M
117.86%15M
-17.36%10M
-752.85%-43.74M
-42.25%34.99M
635.71%9.3M
Cash from discontinued investing activities
Investing cash flow
-32.35%9.91M
-45.54%4.6M
55.32%-19.65M
-117.42%-6M
62.17%14.87M
118.44%14.66M
-28.78%8.45M
-754.84%-43.98M
-64.82%34.46M
-74.95%9.17M
Financing cash flow
Cash flow from continuing financing activities
-15.28%-83K
18.53%659K
4,178.10%35.19M
-101.27%-1.61M
-102.51%-1.23M
61.50%-72K
79.35%556K
-101.10%-863K
367.84%127.47M
39,224.80%49.16M
Net issuance payments of debt
--0
--0
--38.17M
--0
--0
--0
--0
--0
--102.72M
--48.92M
Net common stock issuance
-15.28%-83K
-104.00%-51K
-297.91%-3.43M
-103.42%-1.01M
-133.33%-49K
-157.14%-72K
-733.33%-25K
-102.92%-863K
11.58%29.53M
87.57%-21K
Proceeds from stock option exercised by employees
--0
22.20%710K
--459K
-30.50%581K
--0
--0
13.92%581K
--0
0.12%836K
8.16%318K
Net other financing activities
----
----
----
78.89%-1.19M
----
----
----
----
-10,294.44%-5.61M
---60K
Cash from discontinued financing activities
Financing cash flow
-15.28%-83K
18.53%659K
4,178.10%35.19M
-101.27%-1.61M
-102.51%-1.23M
61.50%-72K
79.35%556K
-101.10%-863K
367.84%127.47M
39,224.80%49.16M
Net cash flow
Beginning cash position
22.20%61.83M
20.93%66.92M
-43.26%71.67M
87.77%126.31M
-39.88%50.57M
-46.93%50.6M
-46.68%55.33M
87.77%126.31M
78.92%67.27M
41.38%84.11M
Current changes in cash
5,751.85%1.53M
-7.39%-5.09M
93.30%-4.76M
-192.54%-54.64M
-49.99%21.11M
99.76%-27K
43.83%-4.74M
-294.47%-70.98M
98.96%59.04M
442.41%42.21M
Effect of exchange rate changes
----
----
----
--0
----
----
----
----
--0
----
End cash Position
25.28%63.36M
22.20%61.83M
20.93%66.92M
-43.26%71.67M
-43.26%71.67M
-39.88%50.57M
-46.93%50.6M
-46.68%55.33M
87.77%126.31M
87.77%126.31M
Free cash flow
43.88%-8.39M
29.73%-10.75M
22.41%-20.47M
52.34%-49.29M
145.16%7.34M
16.59%-14.96M
26.57%-15.29M
45.51%-26.38M
-7.03%-103.42M
44.11%-16.25M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 43.16%-8.31M24.71%-10.35M22.33%-20.3M54.30%-47.02M146.35%7.47M17.71%-14.61M33.31%-13.74M46.00%-26.14M-7.70%-102.89M44.31%-16.12M
Net income from continuing operations -29.12%-15.74M24.38%-15.01M-12.75%-18.98M34.23%-62.26M-3.56%-13.39M44.17%-12.19M24.22%-19.84M50.07%-16.83M22.87%-94.66M74.54%-12.93M
Operating gains losses ------------1,148.84%3.16M2,385.71%320K-------------142.88%-301K-101.77%-14K
Depreciation and amortization -6.94%3.12M-6.21%3.15M1.04%3.21M3.88%13.16M-6.97%3.26M9.31%3.36M9.83%3.36M4.91%3.18M574.19%12.67M289.66%3.5M
Deferred tax -592.44%-3.32M210.96%749K--307K12.29%-1.25M---1.25M--675K---675K--0---1.42M----
Other non cash items 206.09%383K192.79%206K-244.51%-2.79M-182.46%-3M68.28%-1.6M-212.81%-361K-104.17%-222K-126.72%-811K277.94%3.63M-2,257.26%-5.05M
Change In working capital 106.08%674K-398.68%-3.39M59.35%-5.63M82.09%-6.29M682.15%17.51M-343.06%-11.08M120.90%1.13M42.77%-13.86M-396.52%-35.15M-117.58%-3.01M
-Change in receivables 108.27%1.3M-891.50%-5.03M6,043.33%1.78M37.44%-8.37M304.38%6.77M-793.36%-15.74M126.76%635K99.49%-30K-114.43%-13.37M-837.64%-3.31M
-Change in inventory 51.32%-1.05M69.53%-2.27M38.90%-2.33M-98.31%-14.8M74.55%-1.4M-30.09%-2.15M-4,922.30%-7.43M-2,331.21%-3.82M-0.63%-7.47M-142.08%-5.51M
-Change in prepaid assets -37.32%215K-86.31%281K-51.67%-1.86M182.48%3.21M280.34%2.04M118.67%343K337.78%2.05M-2,012.07%-1.23M-218.15%-3.89M-130.71%-1.13M
-Change in payables and accrued expense -153.46%-2.15M-76.80%688K25.32%-5.18M146.21%6.44M701.88%6.39M90.79%4.02M186.42%2.97M39.85%-6.94M-162.46%-13.93M-106.78%-1.06M
-Change in other current liabilities -47.66%358K-90.76%302K118.93%762K113.24%818K199.33%893K--684K--3.27M23.75%-4.03M---6.18M---899K
-Change in other working capital 12.84%2M848.01%2.63M-45.18%1.2M-33.70%6.42M-68.29%2.82M173.26%1.77M-125.34%-352K273.71%2.18M12,671.43%9.68M2,265.21%8.9M
Cash from discontinued investing activities
Operating cash flow 43.16%-8.31M24.71%-10.35M22.33%-20.3M54.30%-47.02M146.35%7.47M17.71%-14.61M33.31%-13.74M46.00%-26.14M-7.70%-102.89M44.31%-16.12M
Investing cash flow
Cash flow from continuing investing activities -32.35%9.91M-45.54%4.6M55.32%-19.65M-117.42%-6M62.17%14.87M118.44%14.66M-28.78%8.45M-754.84%-43.98M-64.82%34.46M-74.95%9.17M
Capital expenditure reported 74.78%-87K74.35%-397K31.09%-164K-331.87%-2.26M0.00%-132K-96.02%-345K-567.24%-1.55M-1,587.50%-238K51.71%-524K-0.76%-132K
Net business purchase and sale --------------0------------------0----
Net investment purchase and sale -33.33%10M-50.00%5M55.45%-19.49M-110.69%-3.74M61.29%15M117.86%15M-17.36%10M-752.85%-43.74M-42.25%34.99M635.71%9.3M
Cash from discontinued investing activities
Investing cash flow -32.35%9.91M-45.54%4.6M55.32%-19.65M-117.42%-6M62.17%14.87M118.44%14.66M-28.78%8.45M-754.84%-43.98M-64.82%34.46M-74.95%9.17M
Financing cash flow
Cash flow from continuing financing activities -15.28%-83K18.53%659K4,178.10%35.19M-101.27%-1.61M-102.51%-1.23M61.50%-72K79.35%556K-101.10%-863K367.84%127.47M39,224.80%49.16M
Net issuance payments of debt --0--0--38.17M--0--0--0--0--0--102.72M--48.92M
Net common stock issuance -15.28%-83K-104.00%-51K-297.91%-3.43M-103.42%-1.01M-133.33%-49K-157.14%-72K-733.33%-25K-102.92%-863K11.58%29.53M87.57%-21K
Proceeds from stock option exercised by employees --022.20%710K--459K-30.50%581K--0--013.92%581K--00.12%836K8.16%318K
Net other financing activities ------------78.89%-1.19M-----------------10,294.44%-5.61M---60K
Cash from discontinued financing activities
Financing cash flow -15.28%-83K18.53%659K4,178.10%35.19M-101.27%-1.61M-102.51%-1.23M61.50%-72K79.35%556K-101.10%-863K367.84%127.47M39,224.80%49.16M
Net cash flow
Beginning cash position 22.20%61.83M20.93%66.92M-43.26%71.67M87.77%126.31M-39.88%50.57M-46.93%50.6M-46.68%55.33M87.77%126.31M78.92%67.27M41.38%84.11M
Current changes in cash 5,751.85%1.53M-7.39%-5.09M93.30%-4.76M-192.54%-54.64M-49.99%21.11M99.76%-27K43.83%-4.74M-294.47%-70.98M98.96%59.04M442.41%42.21M
Effect of exchange rate changes --------------0------------------0----
End cash Position 25.28%63.36M22.20%61.83M20.93%66.92M-43.26%71.67M-43.26%71.67M-39.88%50.57M-46.93%50.6M-46.68%55.33M87.77%126.31M87.77%126.31M
Free cash flow 43.88%-8.39M29.73%-10.75M22.41%-20.47M52.34%-49.29M145.16%7.34M16.59%-14.96M26.57%-15.29M45.51%-26.38M-7.03%-103.42M44.11%-16.25M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Micron Technology
MU
+10.45%
ASML Holding
ASML
+7.58%
Taiwan Semiconductor
TSM
+5.46%
Meta Platforms
META
+4.23%
NVIDIA
NVDA
+3.43%

Unlock the Full List